Gene therapy for tuberous sclerosis
US-2024343768-A1 · Oct 17, 2024 · US
Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
US8940697B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940697-B2 |
| Application number | US-201013502219-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2010 |
| Priority date | Oct 16, 2009 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a method of treating, ameliorating or preventing myocardial ischemia/reperfusion injury in a subject in need thereof, by administering to the subject a therapeutically effective amount of an annexin A1 short peptide (ANXA1sp).
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating and/or ameliorating surgical, global myocardial ischemia/reperfusion injury due to cardiac surgery or cardiac transplantation in a subject having cardiac surgery or cardiac transplantation, comprising administering to said subject an effective amount of an annexin A1 short peptide (ANXA1sp) consisting of the amino acid sequence Ac-Gln-Ala-Trp, wherein the ANXA1sp is administered to the subject prior to during, and/or after cardiac surgery…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- A61K38/1709Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8940697B2 cover?
- The present invention provides a method of treating, ameliorating or preventing myocardial ischemia/reperfusion injury in a subject in need thereof, by administering to the subject a therapeutically effective amount of an annexin A1 short peptide (ANXA1sp).
- Who is the assignee on this patent?
- Podgoreanu Mihai V, Zhang Zhiquan, Ma Qing, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K38/1709. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).